RE-INITIATION OF GUIDELINE-DIRECTED CHRONIC CARDIAC MEDICATIONS IS LIMITED POST-DISCHARGE AMONG CARDIAC INTENSIVE CARE SURVIVORS

Discontinuation of beta blockers (BB) and/or renin-angiotensin aldosterone antagonists (RAAS) during heart failure (HF) admissions is associated with increased mortality. Nonetheless, BB & RAAS discontinuation remains a common occurrence, but the reasons for discontinuations are under-defined.